Literature DB >> 2173409

Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.

L Leoncini1, M T Del Vecchio, R Kraft, T Megha, P Barbini, G Cevenini, S Poggi, S Pileri, P Tosi, H Cottier.   

Abstract

The authors have examined cellular areas of lymphoma tissue in 28 cases of Hodgkin's disease (HD) or anaplastic large cell lymphoma (ALCL, 'Ki-1 cell lymphoma') to evaluate the boundaries between the two entities. Methods applied included conventional histology; test point analysis; semiautomated morphometry of nuclear profile features of Reed-Sternberg and other atypical large cells (RSALCs); and immunohistochemistry of these elements on all paraffin sections and, in 15 cases, on frozen sections. Mean nuclear profile morphotypes of RSALCs per case varied independently of immunophenotype and histologic diagnosis. Conversely, immunohistochemistry demonstrated significant, although not consistent, preferential positivities of these CD30+ elements for CD15 in HD, and for epithelial membrane antigen (EMA) and CD43 in ALCLs. In the latter, RSALCs also exhibited a tendency for CD45 and CD45RO positivity and for the expression of T-cell-associated antigens. However, there were considerable overlaps. This continuous spectrum of RSALC nuclear profile morphotypes and immunophenotypes, ranging from HD over questionable cases, intermediate between HD and ALCL, to ALCLs, was paralleled by differences in the reactive component of lymphomas. Lymphocytes and granulocytes were significantly deficient in ALCLs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173409      PMCID: PMC1877680     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  Immunopathological lymph node findings in Hodgkin's disease: correlation to survival.

Authors:  P Tosi; M Cintorino; P Luzi
Journal:  Res Exp Med (Berl)       Date:  1975-11-26

2.  Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types.

Authors:  J K Chan; C S Ng; P K Hui; T W Leung; E S Lo; W H Lau; L J McGuire
Journal:  Histopathology       Date:  1989-07       Impact factor: 5.087

3.  BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope.

Authors:  R Schwarting; J Gerdes; H Dürkop; B Falini; S Pileri; H Stein
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

4.  Analysis of the Rye classification of Hodgkin's disease. The prognostic significance of cellular composition.

Authors:  L W Coppleson; H Rappaport; S B Strum; J Rose
Journal:  J Natl Cancer Inst       Date:  1973-08       Impact factor: 13.506

5.  Observer disagreement in the classification and histology of Hodgkin's disease.

Authors:  L W Coppleson; R M Factor; S B Strum; P W Graff; H Rappaport
Journal:  J Natl Cancer Inst       Date:  1970-10       Impact factor: 13.506

6.  A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma').

Authors:  R Rimokh; J P Magaud; F Berger; J Samarut; B Coiffier; D Germain; D Y Mason
Journal:  Br J Haematol       Date:  1989-01       Impact factor: 6.998

Review 7.  Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease.

Authors:  R J Lukes
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

8.  Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35).

Authors:  M A Bitter; W A Franklin; R A Larson; T W McKeithan; C M Rubin; M M Le Beau; J K Stephens; J W Vardiman
Journal:  Am J Surg Pathol       Date:  1990-04       Impact factor: 6.394

9.  Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization.

Authors:  I Anagnostopoulos; H Herbst; G Niedobitek; H Stein
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

10.  Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Immunohistochemical and morphological relationships to Hodgkin's disease.

Authors:  R Rosso; M Paulli; U Magrini; S Kindl; E Boveri; G Volpato; S Poggi; P Baglioni; S Pileri
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990
View more
  17 in total

1.  Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas.

Authors:  A Carbone; A Gloghini; R Volpe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Sialosylated Lewis chi expression in CD30-positive anaplastic large-cell lymphomas.

Authors:  K Kasai; Y Sato; S Kuwao; Y Kawakubo; H Inoue; T Kameya
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.

Authors:  S Pittaluga; I Wlodarska; K Pulford; E Campo; S W Morris; H Van den Berghe; C De Wolf-Peeters
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

4.  Classical Hodgkin's disease. Clinical impact of the immunophenotype.

Authors:  R von Wasielewski; M Mengel; R Fischer; M L Hansmann; K Hübner; J Franklin; H Tesch; U Paulus; M Werner; V Diehl; A Georgii
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 5.  Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.

Authors:  Naoko Tsuyama; Kana Sakamoto; Seiji Sakata; Akito Dobashi; Kengo Takeuchi
Journal:  J Clin Exp Hematop       Date:  2017

6.  MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form.

Authors:  R L ten Berge; F G Snijdewint; S von Mensdorff-Pouilly; R J Poort-Keesom; J J Oudejans; J W Meijer; R Willemze; J Hilgers; C J Meijer
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

7.  Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas.

Authors:  L Leoncini; M T Del Vecchio; T Megha; P Barbini; P Galieni; S Pileri; E Sabattini; F Gherlinzoni; P Tosi; R Kraft
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

8.  Inconsistency of the immunophenotype of Reed-Sternberg cells in simultaneous and consecutive specimens from the same patients. A paraffin section evaluation in 56 patients.

Authors:  W S Chu; S L Abbondanzo; G Frizzera
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

9.  Immunoreactivity of CD99 in non-Hodgkin's lymphoma: unexpected frequent expression in ALK-positive anaplastic large cell lymphoma.

Authors:  Chang Ohk Sung; Young H Ko; Sanghui Park; Kihyun Kim; Wonseog Kim
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

10.  PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus.

Authors:  Andrew L Feldman; Mark E Law; David J Inwards; Ahmet Dogan; Rebecca F McClure; William R Macon
Journal:  Mod Pathol       Date:  2010-01-29       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.